TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Aclarion, Inc. ( (ACON) ) has issued an update.
On April 23, 2025, Aclarion, Inc. announced the release of an updated investor presentation in conjunction with its participation at the Planet MicroCap Showcase: VEGAS 2025. The presentation, led by CEO Brent Ness, highlights recent value-driving initiatives and is available on the company’s website. This update is part of Aclarion’s ongoing efforts to leverage its technology in the healthcare sector, specifically addressing chronic low back pain, and may influence its industry positioning and stakeholder interests.
More about Aclarion, Inc.
Aclarion, Inc. is a healthcare technology company that utilizes Magnetic Resonance Spectroscopy (MRS), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to enhance clinical treatments. The company primarily targets the chronic low back pain market with its Nociscan platform, which helps physicians noninvasively identify painful lumbar discs to optimize treatment strategies.
YTD Price Performance: -99.42%
Average Trading Volume: 219,275
Technical Sentiment Signal: Buy
Current Market Cap: $4.37M
See more insights into ACON stock on TipRanks’ Stock Analysis page.